Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thanh H Dellinger

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Cancers|September 15, 2020
Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian CancerWei Wen, Ernest S Han, Thanh H Dellinger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
Surgical Management of Vulvar CancerThanh H Dellinger, Amy A Hakim, Stephen J Lee, et al.
International Urogynecology Journal|August 20, 2018
Concurrent pelvic reconstruction and minimally invasive pelvic cancer surgeryChristopher P Chung, NhuChi T Dao, Mark T Wakabayashi, et al.
International Urogynecology Journal|August 2, 2020
Prolapse repair after anterior exenterationChristopher P Chung, Eizleayne Edrosa, Mark T Wakabayashi, et al.
Oncotarget|January 21, 2021
NSCs are permissive to oncolytic <i>Myxoma virus</i> and provide a delivery method for targeted ovarian cancer therapyYvonne Cornejo, Min Li, Thanh H Dellinger, et al.
Annals of Surgical Oncology|December 21, 2017
The Comprehensive Complication Index: a New Measure of the Burden of Complications After Hyperthermic Intraperitoneal ChemotherapySinziana Dumitra, Michael O'Leary, Mustafa Raoof, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
Pterostilbene in Cancer TherapyElena Obrador, Rosario Salvador-Palmer, Ali Jihad-Jebbar, et al.
Molecular Carcinogenesis|June 3, 2016
Cinnamon extract reduces VEGF expression via suppressing HIF-1α gene expression and inhibits tumor growth in miceKeqiang Zhang, Ernest S Han, Thanh H Dellinger, et al.
Scientific Reports|November 24, 2016
TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signallingCai M Roberts, Michelle A Tran, Mary C Pitruzzello, et al.
Translational Oncology|May 30, 2019
Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian CancerWei Wen, Ernest S Han, Thanh H Dellinger, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Cancers|September 15, 2020
Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian CancerWei Wen, Ernest S Han, Thanh H Dellinger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
Surgical Management of Vulvar CancerThanh H Dellinger, Amy A Hakim, Stephen J Lee, et al.
International Urogynecology Journal|August 20, 2018
Concurrent pelvic reconstruction and minimally invasive pelvic cancer surgeryChristopher P Chung, NhuChi T Dao, Mark T Wakabayashi, et al.
International Urogynecology Journal|August 2, 2020
Prolapse repair after anterior exenterationChristopher P Chung, Eizleayne Edrosa, Mark T Wakabayashi, et al.
Oncotarget|January 21, 2021
NSCs are permissive to oncolytic <i>Myxoma virus</i> and provide a delivery method for targeted ovarian cancer therapyYvonne Cornejo, Min Li, Thanh H Dellinger, et al.
Annals of Surgical Oncology|December 21, 2017
The Comprehensive Complication Index: a New Measure of the Burden of Complications After Hyperthermic Intraperitoneal ChemotherapySinziana Dumitra, Michael O'Leary, Mustafa Raoof, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
Pterostilbene in Cancer TherapyElena Obrador, Rosario Salvador-Palmer, Ali Jihad-Jebbar, et al.
Molecular Carcinogenesis|June 3, 2016
Cinnamon extract reduces VEGF expression via suppressing HIF-1α gene expression and inhibits tumor growth in miceKeqiang Zhang, Ernest S Han, Thanh H Dellinger, et al.
Scientific Reports|November 24, 2016
TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signallingCai M Roberts, Michelle A Tran, Mary C Pitruzzello, et al.
Translational Oncology|May 30, 2019
Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian CancerWei Wen, Ernest S Han, Thanh H Dellinger, et al.
Pageof 5